ArticleFrontiers in oncology2025

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.